Biogen (BIIB) PT Lowered to $382 at SVB Leerink

November 9, 2020 4:39 AM

SVB Leerink analyst Marc H. Goodman lowered the price target on Biogen (NASDAQ: BIIB) to $382.00 (from $402.00) while maintaining a Outperform rating.

No results found